Strain Information | |
---|---|
Image | |
BRC No. | RBRC10201 |
Type | Targeted Mutation Congenic |
Species | Mus musculus |
Strain name | CB17.Cg-Plxnb1<tm1Matl> |
Former Common name | CB17-PlexinB1-KO |
H-2 Haplotype | |
ES Cell line | E14TG2a [129P2/OlaHsd] |
Background strain | |
Appearance | |
Strain development | Developed by Roland H. Friedel and deposited by Shinobu Inagaki, Osaka University Graduate School of Medicine, Division of Health Sciences. E14TG2a ES cells derived from 129P2/OlaHsd were used. This strain was backcrossed to C.B-17/lcr-+/+Jcl for 10 generations. |
Strain description | Plxnb1 (plexin B1) knockout mice. C.B-17/lcr congenic strain. |
Colony maintenance | |
References | Gene targeting using a promoterless gene trap vector ("targeted trapping") is an efficient method to mutate a large fraction of genes. Friedel R H, Plump A, Lu X, Spilker K, Jolicoeur C, Wong K, Venkatesh T R, Yaron A, Hynes M, Chen B, Okada A, McConnell S K, Rayburn H, Tessier-Lavigne M Proc. Natl. Acad. Sci. USA, 102(37) 13188-13193 (2005). 16129827 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
SV40 polyA | 9 | ||||||
human Placental alkaline phosphatase cDNA | 9 | ||||||
CD4 | Rat CD4 cDNA | 9 | CD4 | ||||
En2 | En2 SA (mouse En2 intron 2/exon 3 splice acceptor sequence) | 9 | En2 | ||||
Ires | internal ribosomal entry site (EMCV) | 9 | |||||
Plxnb1 | plexin B1 | 9 | Plxnb1 | targeted mutation 1, Marc Tessier-Lavigne | |||
lacZ | beta-galactosidase (E. coli) | 9 | |||||
neo | neomycin resistance gene | 9 |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | Mouse En2 splice acceptor, Rat CD4 cDNA, E.coli Galactosidase/neomysin phosphotransferase fusion gene (β-geo), Encephalomyocarditis virus (EMCV) internal ribosomal entry site (ires), Human Placental alkaline phosphatase cDNA, SV40 Poly A, mouse Plxnb1 genomic DNA |
Research application | Fluorescent Proteins/lacZ System |
Specific Term and Conditions | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Proc. Natl. Acad. Sci. USA 102: 13188-13193 (2005).In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. RECIPIENT which wants to use the BIOLOGICAL RESOURCE for the purpose other than education or not-for-profit research is requested to enter into a Material Transfer Agreement with Osaka University. |
Depositor | Drs. Tatsuo Furuyama and Shinobu Inagaki (Osaka University) |
Strain Status | Frozen embryos Frozen sperm |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |